For research use only. Not for therapeutic Use.
Rovalpituzumab is a humanized monoclonal antibody against delta-like protein 3 (DLL3). Rovalpituzumab can be used in the synthesis of antibody-drug conjugate (ADC), Rovalpituzumab Tesirine[1]. Rovalpituzumab has activity against small cell lung cancer (SCLC)[1].
| Catalog Number | I043765 |
| CAS Number | 1613313-01-1 |
| Purity | ≥95% |
| Reference | [1]. Bilal H Lashari, et al. Rovalpituzumab Tesirine: A Novel DLL3-Targeting Antibody-Drug Conjugate. Drugs R D. 2018 Dec;18(4):255-258. |
